Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 108
Number of items: 108
  • Open Access
    Albers, E. A. C., Luijendijk, M. J., Egeler, M., Fraterman, I., Lucas, M. W., de Ligt, K. M., Schagen, S. B., Blank, C. U., & van de Poll-Franse, L. V. (2025). Cross-sectional study of long-term Health-Related Quality of Life in stage III melanoma patients receiving neo-adjuvant versus adjuvant immune checkpoint inhibitors. European Journal of Cancer, 229, Article 115710. https://doi.org/10.1016/j.ejca.2025.115710
  • Open Access
    Albers, E. A. C., de Ligt, K. M., van der Ploeg, I. M. C., Wouters, M. J. W. M., Schagen, S. B., & van de Poll-Franse, L. V. (2025). Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patients. Supportive Care in Cancer, 33(4), Article 273. https://doi.org/10.1007/s00520-025-09325-9
  • Open Access
    Luijendijk, M. J., Lee Meeuw Kjoe, P. R., Wortelboer, N., van Ommen-Nijhof, A., van Leeuwen-Stok, A. E., Agelink van Rentergem, J. A., Vermeulen, I. E., Konings, I. R., Jager, A., Sonke, G. S., van der Wall, E., & Schagen, S. B. (2025). Cognitive function during endocrine treatment with or without cyclin-dependent kinase 4/6 inhibitors for advanced breast cancer. Cancer, 131(24), Article e70212. https://doi.org/10.1002/cncr.70212
  • Open Access
    Wefel, J. S., & Schagen, S. B. (2025). Neuropsychological sequelae of cancer and cancer therapy. Journal of Clinical and Experimental Neuropsychology, 47(8), 701-706. https://doi.org/10.1080/13803395.2025.2601390
  • Open Access
    Kuil, L. E., van Scheppingen, R. H., Leter, Y. M., Röring, B. H., de Gooijer, M. C., van Heijningen, C. L., Prekovic, S., Compter, A., van Tellingen, O., & Schagen, S. B. (2025). Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescence. Neuro-Oncology, 27(11), 2894-2908. https://doi.org/10.1093/neuonc/noaf146
  • Open Access
    Luijendijk, M. J., Buijs, S. M., Jager, A., Koolen, S. L. W., van der Wall, E., Schagen, S. B., & Mathijssen, R. H. J. (2025). Effects of tamoxifen on cognitive function in patients with primary breast cancer. British Journal of Cancer, 132(2), 180–187. https://doi.org/10.1038/s41416-024-02914-1
  • Zeng, H., Hendriks, L. E. L., Belderbos, J., Brandts, L., Compter, I., Dubois, L., Holt, M. G., Houben, R., Schagen, S., Zhang, X., Prezzemolo, T., & De Ruysscher, D. (2024). Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial. Clinical Lung Cancer, 25(7), 653-659.e1. https://doi.org/10.1016/j.cllc.2024.08.008
  • Open Access
    Rojas-Saunero, L. P., van der Willik, K. D., Schagen, S. B., Ikram, M. A., & Swanson, S. A. (2024). Towards a Clearer Causal Question Underlying the Association between Cancer and Dementia. Epidemiology, 35(3), 281-288. https://doi.org/10.1097/EDE.0000000000001712
  • Open Access
    Koevoets, E. W., Stuiver, M. M., de Ruiter, M. B., Schagen, S. B., & PAM Study Group (2024). Effect of Physical Exercise on MRI-Assessed Brain Perfusion in Chemotherapy-Treated Breast Cancer Patients: A Randomized Controlled Trial. Journal of Magnetic Resonance Imaging, 59(5), 1667-1680. https://doi.org/10.1002/jmri.28967
  • Open Access
    Hiensch, A. E., Beckhaus, J., Witlox, L., Monninkhof, E. M., Schagen, S. B., van Vulpen, J. K., Sweegers, M. G., Newton, R. U., Aaronson, N. K., Galvão, D. A., Steindorf, K., Stuiver, M. M., Mesters, I., Knoop, H., Goedendorp, M. M., Bohus, M., Thorsen, L., Schulz, K.-H., Schmidt, M. E., ... May, A. M. (2024). Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis. Journal of Cancer Survivorship, 18(5), 1492-1503. https://doi.org/10.1007/s11764-023-01392-3
Page 2 of 11